Cancer Diagnostics Market, By Diagnostics Type, By Cancer Type, By Technology, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Description

Cancer Diagnostics Market size was valued at US$ 110,287.6 Million in 2025, expanding at a CAGR of 6.23% from 2026 to 2033.

Cancer diagnostics indicates to the medical process used to detect, identify, and confirm the presence of cancer in the human body. It comprises a combination of tests such as imaging scans, laboratory analysis, genetic testing, and tissue examination. These procedures help doctors understand whether abnormal cells are cancerous, verify the type of cancer, and measure its stage. Early and accurate diagnosis plays a vital role in advancing treatment decisions and patient outcomes. According to the World Health Organization, cancer remains one of the main reasons of death globally, with around 10 million deaths annually, highlighting the importance of early and accurate diagnosis for improving survival consequences. The International Agency for Research on Cancer also reports a steady increase in cancer cases, encouraging countries to strengthen screening and diagnostic infrastructure. Governments across multiple regions are investing in early screening initiatives and advanced laboratory capabilities to improve detection accuracy and reduce late-stage diagnosis, supporting better clinical outcomes and healthcare planning.

Cancer Diagnostics Market- Market Dynamics

Expanding healthcare infrastructure and diagnostic laboratory networks

Constant development of healthcare facilities and diagnostic laboratories is improving access to cancer testing services over diverse healthcare atmospheres. As more hospitals, clinics, and specific diagnostic centers are recognized or elevated, patients are able to get timely screening and confirmatory tests without long interruptions. Governments are investing in supporting diagnostic infrastructure to ensure wider and faster accessibility of testing services. For example, France's Ministry of Health continues to enhance hospital-based diagnostic capabilities, while India's National Health Mission supports the expansion of district-level diagnostic laboratories.

Additionally, Japan's healthcare system under MHLW sustains a strong network of hospitals prepared with advanced diagnostic and pathology services to provision early cancer detection. From the corporate perspective, GE HealthCare is expanding imaging equipment deployment across hospitals to improve diagnostic accessibility, while Abbott s increasing distribution of point-of-care diagnostic systems for faster laboratory results. These progresses are helping lessen delays in cancer detection and improving diagnostic reach in both urban and semi-urban healthcare centers.

Cancer Diagnostics Market- Segmentation Analysis:

The Global Cancer Diagnostics Market is segmented on the basis of Diagnostics Type, Cancer Type, Technology, End User, and Region.

Looking at different diagnostic type, market varies into five types: diagnostic imaging tests, tumor biomarkers, biopsy & cytology tests, IVD immunoassays and genomic / liquid-biopsy tests. Diagnostic Imaging Tests maintain a strong and consistent presence in cancer detection practices because they are widely used at the first stage of clinical evaluation. These tests help doctors visually identify abnormal growths, determine tumor location, and assess disease spread in a non-invasive manner, making them a preferred starting point in many healthcare settings. On the industry side, Canon Medical Systems has expanded its advanced CT and MRI imaging solutions designed to support oncology diagnostics with improved image precision and faster scan processing.

Under technology segmentation, molecular diagnostics is increasingly anticipated to play a central role as it helps identify disease at a genetic and cellular level. This approach enables earlier detection of mutations, better cancer classification, and more precise treatment planning compared to traditional methods. It is widely used in personalized medicine, where treatment is tailored based on individual genetic profiles, improving clinical decision-making in oncology care. From the corporate standpoint, Thermo Fisher Scientific has expanded its molecular testing portfolio, including PCR-based oncology assays that support faster and more accurate cancer mutation detection. Similarly, Roche Diagnostics has strengthened its molecular diagnostics solutions by developing advanced PCR and companion diagnostic platforms used for identifying cancer biomarkers and guiding targeted therapies.

Cancer Diagnostics Market- Geographical Insights

Across global markets, the development of cancer diagnostics exhibits varying clinical infrastructure strength, screening awareness, and implementation of advanced medical skills. Among all regions, North America is projected to account for a substantial share, as it reinforced by strong healthcare expenditure, structured screening plans, and rapid uptake of precision oncology tools. For instance, the Centers for Disease Control and Prevention (CDC) states nearly 1.9 million new cancer cases annually in the United States, prominence high diagnostic demand. The National Cancer Institute (NCI) continues to support cancer research and innovation with multi-billion-dollar funding each year, supporting early detection plans. On the other side, Siemens Healthineers has extended its AI-assisted imaging systems to enhance tumor detection accuracy in clinical workflows, while Illumina's next-generation sequencing platforms are widely participated into oncology testing for identifying genetic changes and guiding personalized treatment decisions. These factors support acceptance of advanced cancer diagnostics regionwide steadily.

Within this region, Canada exhibits solid public healthcare support, early screening adoption, and structured national reporting systems that help in timely disease detection and management. According to the Canadian Cancer Society, nearly 1 in 2 Canadians is expected to develop cancer during their lifetime, signaling the importance of continuous diagnostic surveillance and preventive screening programs. In the same way, Statistics Canada and Canadian Cancer Society report that 240,000 cancer cases are diagnosed annually, with tens of thousands of related deaths, reinforcing the need for early diagnostic intervention. Government-backed initiatives under the Public Health Agency of Canada further inspire planned screening for breast, cervical, and colorectal cancers, firming early identification practices across areas.

Japan Cancer Diagnostics Market- Country Insights

Japan's cancer diagnostics atmosphere is formed by an organized healthcare system, strong focus on preventive care, and wide acceptance of advanced medical technologies. The country places its importance on early detection, reinforced by routine health checkups and structured screening programs that reassure timely identification of cancer even before symptoms appear. According to the National Cancer Center Japan, around 1 million new cancer cases are reported annually, reflecting growing diagnostic demand. The Ministry of Health, Labour and Welfare (MHLW) notes that cancer-related deaths are approximately 380,000 each year, emphasizing the importance of timely diagnosis and intervention. In addition, the National Cancer Center highlights that nearly 1 in 2 people in Japan may develop cancer during their lifetime, strengthening the need for continuous screening awareness. On the business side, Fujifilm Holdings Corporation has expanded its AI-assisted imaging and endoscopy solutions across Japanese hospitals, supporting earlier identification of gastrointestinal and other cancers through improved diagnostic clarity.

Cancer Diagnostics Market- Competitive Landscape:

Due to the rising essential for early disease detection and precise clinical decision-making, the Cancer Diagnostics market is influenced by a wide mix of healthcare companies, laboratory service providers, and technology-determined firms working through imaging, pathology, and molecular testing. Key contributors such as Siemens Healthineers, GE HealthCare, Abbott, Illumina, and Thermo Fisher Scientific emphasis on improving diagnostic precision through advanced imaging systems, genetic sequencing tools, and AI-supported analysis platforms. Companies generally deliver their solutions via hospitals, diagnostic laboratories, research institutes, and specialized screening centers, while also expanding access through digital health platforms and automated lab networks. They discriminate themselves through innovation in biomarker discovery, test accuracy, speed of reporting, affordability, and integration of artificial intelligence in diagnostic workflows. Recent developments include Siemens Healthineers expanding its AI-powered imaging ecosystem to support faster tumor detection workflows, and Illumina advancing its next-generation sequencing solutions to improve early cancer mutation identification and personalized treatment planning.

Recent Developments:

In April 2026, Roche advanced its diagnostics expansion strategy by agreeing to acquire SAGA Diagnostics, strengthening its molecular residual disease (MRD) testing portfolio. The platform is expected to improve ultra-sensitive cancer detection and help monitor disease recurrence at earlier stages with higher precision.

In October 2025, Blackstone and TPG announced a private equity acquisition of Hologic, a diagnostics company with strong cancer screening capabilities in breast and cervical health. The transaction is expected to support expansion in women-focused cancer detection technologies and molecular diagnostics innovation.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories
Agilent Technologies Inc.
Becton, Dickinson and Company (BD)
bioMerieux
Bio-Rad Laboratories Inc.
F. Hoffmann-La Roche Ltd
GE HealthCare
Hologic Inc.
Illumina Inc.
Canon Medical Systems
Roche Diagnostics
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Qiagen N.V.
Quest Diagnostics
Danaher Corporation
PerkinElmer Inc.
Philips Healthcare
Caris Life Sciences
Cancer Genetics Inc.
Others

GLOBAL CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE- MARKET ANALYSIS, 2020 - 2033

Diagnostic Imaging Tests
Tumor Biomarkers
Biopsy & Cytology Tests
IVD Immunoassays
Genomic / Liquid-Biopsy Tests
Others

GLOBAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE- MARKET ANALYSIS, 2020 - 2033

Liver Cancer
Breast Cancer
Cervical Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Pancreatic Cancer
Kidney Cancer
Ovarian Cancer
Others

GLOBAL CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

Immunodiagnostics
Diagnostic Imaging Technologies
Molecular Diagnostics
Next- Generation Sequencing (NGS)
Others

GLOBAL CANCER DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

Hospitals
Diagnostic Laboratories
POC / Ambulatory Centres
Academic & Research Institutes
Others

GLOBAL CANCER DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

Product Code: ANV6548

1. Cancer Diagnostics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Cancer Diagnostics Market Snippet by Diagnostics Type
- 2.1.2. Cancer Diagnostics Market Snippet by Cancer Type
- 2.1.3. Cancer Diagnostics Market Snippet by Technology
- 2.1.4. Cancer Diagnostics Market Snippet by End User
- 2.1.5. Cancer Diagnostics Market Snippet by Country
- 2.1.6. Cancer Diagnostics Market Snippet by Region
2.2. Competitive Insights

3. Cancer Diagnostics Key Market Trends

3.1. Cancer Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Cancer Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Cancer Diagnostics Market Opportunities
3.4. Cancer Diagnostics Market Future Trends

4. Cancer Diagnostics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Cancer Diagnostics Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Cancer Diagnostics Market Landscape

6.1. Cancer Diagnostics Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Cancer Diagnostics Market - By Diagnostics Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Diagnostics Type, 2025 & 2033 (%)
- 7.1.2. Diagnostic Imaging Tests
- 7.1.3. Tumor Biomarkers
- 7.1.4. Biopsy & Cytology Tests
- 7.1.5. IVD Immunoassays
- 7.1.6. Genomic / Liquid-Biopsy Tests
- 7.1.7. Others

8. Cancer Diagnostics Market - By Cancer Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Cancer Type, 2025 & 2033 (%)
- 8.1.2. Liver Cancer
- 8.1.3. Breast Cancer
- 8.1.4. Cervical Cancer
- 8.1.5. Colorectal Cancer
- 8.1.6. Lung Cancer
- 8.1.7. Prostate Cancer
- 8.1.8. Pancreatic Cancer
- 8.1.9. Kidney Cancer, Ovarian Cancer

9. Cancer Diagnostics Market - By Technology

9.1. Overview
- 9.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
- 9.1.2. Immunodiagnostics
- 9.1.3. Diagnostic Imaging Technologies
- 9.1.4. Molecular Diagnostics
- 9.1.5. NGS
- 9.1.6. Others

10. Cancer Diagnostics Market - By End User

10.1. Overview
- 10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
- 10.1.2. Hospitals
- 10.1.3. Diagnostic Laboratories
- 10.1.4. POC / Ambulatory Centres
- 10.1.5. Academic & Research Institutes
- 10.1.6. Others

11. Cancer Diagnostics Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Cancer Diagnostics Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Cancer Diagnostics Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.17. Denmark
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.17.3. Poland Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.3.17.4. Denmark Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.3.17.5. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.18. Rest of Europe
  - 11.3.18.1. Overview
  - 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.18.3. Rest of the Europe Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.3.18.4. Rest of the Europe Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Cancer Diagnostics Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.16. Taiwan
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.16.3. Taiwan Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.4.16.4. Taiwan Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.4.16.5. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.17. Vietnam
  - 11.4.17.1. Overview
  - 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.17.3. Vietnam Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.4.17.4. Vietnam Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.4.17.5. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.18. Rest of APAC
  - 11.4.18.1. Overview
  - 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.18.3. Rest of APAC Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.4.18.4. Rest of APAC Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.4.18.5. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Cancer Diagnostics Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Cancer Diagnostics Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.14. Iran
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.14.3. Iran Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.6.14.4. Iran Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.6.14.5. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.15. Qatar
  - 11.6.15.1. Overview
  - 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.15.3. Qatar Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.6.15.4. Qatar Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.6.15.5. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.16. Rest of MEA
  - 11.6.16.1. Overview
  - 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.16.3. Rest of MEA Market Size and Forecast, By Diagnostics Type, 2020 - 2033 (US$ Million)
  - 11.6.16.4. Rest of MEA Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 11.6.16.5. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Cancer Diagnostics Industry

12.1. Competitive Benchmarking
- 12.1.1. Competitive Dashboard
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Abbott Laboratories
- 12.2.2. Agilent Technologies Inc.
- 12.2.3. Becton, Dickinson and Company (BD)
- 12.2.4. bioMerieux
- 12.2.5. Bio-Rad Laboratories Inc.
- 12.2.6. F. Hoffmann-La Roche Ltd
- 12.2.7. GE HealthCare
- 12.2.8. Hologic Inc.
- 12.2.9. Illumina Inc.
- 12.2.10. Canon Medical Systems
- 12.2.11. Roche Diagnostics
- 12.2.12. Siemens Healthineers AG
- 12.2.13. Thermo Fisher Scientific Inc.
- 12.2.14. Qiagen N.V.
- 12.2.15. Quest Diagnostics
- 12.2.16. Danaher Corporation
- 12.2.17. PerkinElmer Inc.
- 12.2.18. Philips Healthcare
- 12.2.19. Caris Life Sciences
- 12.2.20. Cancer Genetics Inc.
- 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us